Results 131 to 140 of about 2,655 (208)

Decoding the long-term safety of anti-CGRP (receptor) mAbs: a meta-analysis and systematic review. [PDF]

J Headache Pain
Hoehne CL, Overeem LH, Sanchez-Del-Rio M, Deligianni C, Gil-Gouveia R, Versijpt J, Amin FM, Lampl C, Ryliskiene K, Tronvik E, Coppola G, Holland PR, MaassenVanDenBrink A, Martelletti P, Reuter U, European Headache Federation, EHF.   +16 more
europepmc   +1 more source

Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine [PDF]

, 2019
Day, K., Nagy, A. J., Pearlman, E., Rosen, N., Ruff, D.   +4 more
core   +3 more sources

Changes in interictal cerebral blood flow observed in migraine patients who respond to anti-calcitonin gene-related peptide therapy. [PDF]

Sci Rep
Shimoda M, Hoshikawa K, Oda S, Imai M, Aoki R, Shinohara C.   +5 more
europepmc   +1 more source

Potential therapeutic role of calcitonin gene-related peptide medications for tinnitus. [PDF]

J Chin Med Assoc
Dichter A, Bhatt K, Gutiérrez Pérez ML, Lee EJ, Tawk K, Djalilian HR.   +5 more
europepmc   +1 more source

Patient Adherence and Long-Term Tolerability of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention: A Systematic Review. [PDF]

Cureus
Ray R, Virk GS, Regmi N, Shafiq MM, Siddique R, Elfatih Elamin A, Jihad Y, Ali A, Devi H, Essani B.   +9 more
europepmc   +1 more source

Can atogepant be a preventive treatment for cluster headache?-Insights from a case series. [PDF]

Headache
Serrão C, Sotero FD, Kauppila LA, Martins IP.   +3 more
europepmc   +1 more source

Persistence, switching, and healthcare use after initiating calcitonin gene-related peptide inhibitors: a real-world assessment. [PDF]

J Headache Pain
Moura CS, Randall JR, Klarenbach S, Behlouli H, Luu H, Amoozegar F, Kaboré JL, Bernatsky S.   +7 more
europepmc   +1 more source

Estimating risk of reported versus theoretical drug-drug interactions in headaches medicine: an exhaustive comparison between DrugBank and FAERS database for abortive and preventive combinations. [PDF]

J Oral Facial Pain Headache
Kaytser V, Hakkinen I, Dave J, Zhang P.
europepmc   +1 more source

Prescription of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for the Prophylaxis of Migraine in Austria: A Retrospective, Longitudinal Analysis of Nationwide Insurance Data. [PDF]

Eur J Neurol
Zebenholzer K, Gleiss A, Reichardt B, Gall W, Wöber C.   +4 more
europepmc   +1 more source

Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed. [PDF]

Adv Ther
Mitsikostas DD, Awad SF, Kongerslev R, Boserup LP, Lee XY, Phul R, Sacco S.   +6 more
europepmc   +1 more source